Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2013 1
2015 1
2016 3
2017 7
2018 8
2019 3
2020 10
2021 10
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Author response to Cunha et al.
Colen RR, Rolfo C, Ak M, Ayoub M, Ahmed S, Elshafeey N, Mamindla P, Zinn PO, Ng C, Vikram R, Bakas S, Peterson CB, Rodon Ahnert J, Subbiah V, Karp DD, Stephen B, Hajjar J, Naing A. Colen RR, et al. Among authors: hajjar j. J Immunother Cancer. 2021 Jul;9(7):e003299. doi: 10.1136/jitc-2021-003299. J Immunother Cancer. 2021. PMID: 34315823 Free PMC article.
T-cell agonists in cancer immunotherapy.
Choi Y, Shi Y, Haymaker CL, Naing A, Ciliberto G, Hajjar J. Choi Y, et al. Among authors: hajjar j. J Immunother Cancer. 2020 Oct;8(2):e000966. doi: 10.1136/jitc-2020-000966. J Immunother Cancer. 2020. PMID: 33020242 Free PMC article. Review.
Immune System in Action.
Stephen B, Hajjar J. Stephen B, et al. Among authors: hajjar j. Adv Exp Med Biol. 2021;1342:1-43. doi: 10.1007/978-3-030-79308-1_1. Adv Exp Med Biol. 2021. PMID: 34972961
Metformin: an old drug with new potential.
Hajjar J, Habra MA, Naing A. Hajjar J, et al. Expert Opin Investig Drugs. 2013 Dec;22(12):1511-7. doi: 10.1517/13543784.2013.833604. Epub 2013 Aug 26. Expert Opin Investig Drugs. 2013. PMID: 23978196 Review.
Targeting the indoleamine 2,3-dioxygenase pathway in cancer.
Moon YW, Hajjar J, Hwu P, Naing A. Moon YW, et al. Among authors: hajjar j. J Immunother Cancer. 2015 Dec 15;3:51. doi: 10.1186/s40425-015-0094-9. eCollection 2015. J Immunother Cancer. 2015. PMID: 26674411 Free PMC article. Review.
Use of Genetic Testing for Primary Immunodeficiency Patients.
Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Tan Y, Kobrynski L, Paris K, Torgerson TR, Verbsky JW, Wasserman RL, Hsieh EWY, Blessing JJ, Chou JS, Lawrence MG, Marsh RA, Rosenzweig SD, Orange JS, Abraham RS. Heimall JR, et al. Among authors: hajjar j. J Clin Immunol. 2018 Apr;38(3):320-329. doi: 10.1007/s10875-018-0489-8. Epub 2018 Apr 19. J Clin Immunol. 2018. PMID: 29675737 Review.
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.
Stephen B, Hajjar J, Sarda S, Duose DY, Conroy JM, Morrison C, Alshawa A, Xu M, Zarifa A, Patel SP, Yuan Y, Kwiatkowski E, Wang L, Rodon Ahnert J, Fu S, Meric-Bernstam F, Lowman GM, Looney T, Naing A. Stephen B, et al. Among authors: hajjar j. J Immunother Cancer. 2023 Aug;11(8):e007236. doi: 10.1136/jitc-2023-007236. J Immunother Cancer. 2023. PMID: 37604642 Free PMC article.
45 results